Bioceres Crop Solutions (NASDAQ:BIOX) Issues Earnings Results, Misses Estimates By $0.11 EPS

Bioceres Crop Solutions (NASDAQ:BIOX) released its quarterly earnings results on Monday. The company reported ($0.09) earnings per share for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11), Zacks reports. The business had revenue of $92.60 million for the quarter, compared to analysts’ expectations of $117.15 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. During the same quarter in the prior year, the company posted ($0.07) earnings per share.

Bioceres Crop Solutions Stock Up 8.3 %

BIOX traded up $0.55 on Wednesday, reaching $7.21. The company’s stock had a trading volume of 323,950 shares, compared to its average volume of 171,344. The stock has a market cap of $453.15 million, a price-to-earnings ratio of 360.68 and a beta of 0.49. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.24 and a quick ratio of 0.86. Bioceres Crop Solutions has a 1 year low of $5.71 and a 1 year high of $14.05. The business’s 50 day moving average is $7.73 and its 200 day moving average is $9.85.

Wall Street Analysts Forecast Growth

A number of research firms have commented on BIOX. Lake Street Capital decreased their price target on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, September 11th. Canaccord Genuity Group raised shares of Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Canaccord Genuity Group dropped their price target on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a research note on Wednesday. Roth Mkm reduced their price objective on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, September 11th. Finally, Oppenheimer cut their price target on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a report on Monday, October 21st. Four research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $12.13.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.